Champions Oncology (CSBR) Free Cash Flow Growth (1y) (2011 - 2026)
Champions Oncology (CSBR) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 9.25% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -38.10% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 38.94% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 96.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 152.82% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.34% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 58.53% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 31.57% |
| 10 | Champions Oncology | 68.61 Mn | 68.61 Mn | 7.03 Mn | -132.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -132.39% |
| Jan 31, 2026 | -982.05% |
| Oct 31, 2025 | -360.74% |
| Jul 31, 2025 | 0.96% |
| Apr 30, 2025 | 480.97% |
| Jan 31, 2025 | 115.43% |
| Oct 31, 2024 | -173.92% |
| Jul 31, 2024 | 106.68% |
| Apr 30, 2024 | -24.86% |
| Jan 31, 2024 | -223.44% |
| Oct 31, 2023 | -80.98% |
| Jul 31, 2023 | -390.94% |
| Apr 30, 2023 | -600.69% |
| Jan 31, 2023 | -78.74% |
| Oct 31, 2022 | 305.14% |
| Jul 31, 2022 | -37.34% |
| Apr 30, 2022 | 110.23% |
| Jan 31, 2022 | 460.67% |
| Oct 31, 2021 | 77.48% |
| Jul 31, 2021 | 51.78% |